Capsida Biotherapeutics
Cell & Gene Therapy · Biotechnology

Capsida Biotherapeutics: Risk & public record

Capsida Biotherapeutics: 9 research papers in five years.

Data updated Nov 21, 2026 · Back to the company report

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Public record

Capsida Biotherapeutics: 9 research papers in five years.

Research outputpapers its people wrote, per OpenAlex
9papers in five years
219citations
Virus-based gene therapy research
Biochemistry, Genetics and Molecular Biology
5 papers
Dementia and Cognitive Impairment Research
Medicine
4 papers
Alzheimer's disease research and treatments
Neuroscience
4 papers
RNA Interference and Gene Delivery
Biochemistry, Genetics and Molecular Biology
3 papers
Barrier Structure and Function Studies
Neuroscience
3 papers
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.